Signal

Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019

Evidence first: scan the strongest sources, then decide whether to go deeper.

rss
united_states
Source links limited
You can inspect the signal and top sources here. Full source links and workflow tools unlock on the flagship sample or in the app.
Evidence preview
  • Influenza vaccine effectiveness against outpatient acute respiratory illness with laboratory-confirmed influenza, Uni...
    medRxiv (all subjects)
  • Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE N...
    medRxiv (all subjects)
Overview

Background: Influenza A(H1N1)pdm09 and A(H3N2) viruses predominated during the 2024-25 U.S. influenza season. We estimated influenza vaccine effectiveness (VE) in the United States against mild-to-moderate outpatient influenza illness by influenza type and subtype in the 2024-25 season.

Score total
0.75
Momentum 24h
2
Posts
2
Origins
1
Source types
1
Duplicate ratio
0%